perspectives
We are passionate about using our voices to advance our mission of developing life-transforming therapies for people living with serious muscle diseases.
We are passionate about using our voices to advance our mission of developing life-transforming therapies for people living with serious muscle diseases.
Sep 15, 2021
Starting a New Tradition of Support
by Molly White, Dyne’s vice president, global head of patient advocacy and engagement
Read more
Jul 8, 2021 |
Playing To Win: Building A Position Of Strength In Biotech
by Josh Brumm
Read moreApril 28, 2021 | BLOG
Toward a brighter future: targeting the genetic basis of rare muscle diseases
By Romesh Subramanian, Ph.D.
Read moreApril 8, 2021 | BLOG
Scaling culture with growth: how to maintain your startup’s “special sauce”
By Joshua Brumm
Read moreJan 8, 2021 | Life Science Leader panel
Preparing to pitch in a virtual world
Featuring Joshua Brumm
WatchDec 16, 2020 | BLOG
Beyond the balance sheet: thinking broadly about dilution in building a transformative biotech
By Joshua Brumm
Read moreDec 14, 2020 | BLOG
Voice of the patient – the biopharma perspective
By Molly White
Read moreOct 21, 2020 | PODCAST
FSHD Society Radio
By Molly White
ListenOct 13, 2020 | BLOG
The power of hope: a joint perspective on finding balance in the search for life-changing therapies
By Joachim Boekelmann and Joshua Brumm
Read moreApril 30, 2020 | BLOG
Ordinary people achieving the extraordinary: lessons in leadership from the court to the c-suite
By Joshua Brumm
Read moreadditional content
Hear more from Dyne Therapeutics
Hear more from our CEO, Joshua Brumm
I’m thrilled to join Amphista as Chairman and I’m looking forward to the opportunity we have to advance a unique approach to targeted protein degradation and develop transformational therapies for patients. https://prn.to/3AvD95l
